HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of 4G-beta-D-galactosylsucrose (lactosucrose) on fecal microflora in patients with chronic inflammatory bowel disease.

Abstract
Metabolic interaction between the intestinal microflora and the host has been suggested to play a role in the pathogenesis of chronic inflammatory bowel disease. Elemental or low-fat, low-residual diets in patients with Crohn's disease or ulcerative colitis are reported to decrease anaerobic bacteria and to change the composition of the intestinal microflora. We examined the effect of an indigestible agent, 4G-beta-D-galactosylsucrose (lactosucrose), which is selectively utilized by intestinal Bifidobacterium, on the composition of the intestinal microflora. After the administration of lactosucrose to two patients with Crohn's disease and five patients with ulcerative colitis for 2 weeks, significant induction of the growth of Bifidobacterium was observed, and significant reduction in the population level of Bacteroidaceae was seen. Bowel movements improved in four patients. The intestinal environment, estimated by measuring fecal pH, fecal levels of short-chain fatty acids and putrid products, and the urinary secretion of indican, also improved in these patients. These results suggest that lactosucrose may be useful for patients with chronic inflammatory bowel disease.
AuthorsF Teramoto, K Rokutan, Y Kawakami, Y Fujimura, J Uchida, K Oku, M Oka, M Yoneyama
JournalJournal of gastroenterology (J Gastroenterol) Vol. 31 Issue 1 Pg. 33-9 (Feb 1996) ISSN: 0944-1174 [Print] Japan
PMID8808426 (Publication Type: Journal Article)
Chemical References
  • Trisaccharides
  • galactosucrose
Topics
  • Adolescent
  • Adult
  • Aged
  • Bifidobacterium (drug effects, isolation & purification)
  • Colitis, Ulcerative (microbiology, pathology)
  • Crohn Disease (drug therapy, microbiology, pathology)
  • Feces (microbiology)
  • Female
  • Humans
  • Inflammatory Bowel Diseases (drug therapy, microbiology, pathology)
  • Intestinal Mucosa (drug effects, microbiology)
  • Male
  • Middle Aged
  • Trisaccharides (administration & dosage, pharmacology)
  • Urinalysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: